VAERS 2620826
MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255A
- Staat
- TX
- Alter
- -
- Geschlecht
- F
- Eingang
- 27.09.2023
- Impfdatum
- 24.02.2023
- Beginn
- 25.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LL
Symptomtext
Febrile convulsion; Parent reports fever 101.3 and staring episode the day after vaccine; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2620826-1. The original narrative from the sender is as follows: Concomitant medication included Vitamin D for unknown indication. Parent reports fever of 101.3 and staring episode the day after vaccine,? febrile seizure. The reporter did not provide an assessment of causal relationship between Vaxelis and the event "patient reports fever of 101.3 and staring episode the day after vaccine,? febrile seizure.". No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Febrile convulsion
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- VITAMIN D3
- Allergien
- -
- Vorherige Impfungen
- -